Explore our award and grant recipients
The Doherty Institute is committed to fostering excellence and innovation. This page highlights the funding opportunities and awards that recognise the outstanding contributions of our staff and graduate researchers.
Presented by Australasian Proteomics Society (APS).
Presented by Australasian Sexual and Reproductive Health Alliance (ASHRA).
Presented by the Australian and New Zealand Society for Immunology.
Presented by The Australian Society for Microbiology.
Presented by The Australian Society for Microbiology.
Presented by the Governor-General of Australia.
Presented by University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences (MDHS) | MDHS Award for Research Achievements
Presented by Hepatitis B Voices Australia.
Presented by the Doherty Insitute.
Presented by the Governor-General of Australia.
Presented by the University of Melbourne’s Faculty of Medicine, Dentistry and Health Sciences.
Presented by the University of Melbourne’s Faculty of Medicine, Dentistry and Health Sciences.
Presented by Australian Clinical Trials Alliance (ACTA)
Presented by the University of Melbourne.
Presented by CD1-MR1 2025.
Presented by European Scientific Working group on Influenza (ESWI).
Control of endemic HTLV-1 to prevent silent global spread.
The ASPIRE program is led by Japan’s Agency for Medical Research and Development (AMED), Australia’s National Health and Medical Research Council (NHMRC).
MEGA-dose aSCORbatE for Sepsis (MEGASCORES): An interdisciplinary research program to transform management of sepsis in intensive care units
Defining immune responses capable of eradicating metastatic melanoma.
MEGA-dose aSCORbatE for Sepsis (MEGASCORES): An interdisciplinary research program to transform management of sepsis in intensive care units
Exploiting the unique functions of MAIT cells to drive the rational design of new vaccines and immunotherapies.
Profiling protective antibody responses against infectious diseases.
Genomics-driven innovations to tackle drug-resistant bacterial infections.
Harnessing pathogen genomics to combat current and future threats of drug-resistant enteric bacteria.
Harnessing MAIT cell biology and therapeutics to improve immunotherapy.
Solving the surveillance challenges for malaria elimination in high burden countries.
Generating a universal influenza vaccine.
Establishing protective immunity against antigenically diverse viruses.
Epidemiology, evolution and prevention of streptococcal pandemics.
Recent news, podcasts, events and more from across the Doherty Institute.
Public Health
